These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis. Rodríguez-Arellanes G, Taylor ML, Pérez-Torres A, Curiel-Quesada E, Vargas-Mendoza CF, Martínez-Rivera MA. Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469 [Abstract] [Full Text] [Related]
10. In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India. Kathuria S, Singh PK, Meis JF, Chowdhary A. Antimicrob Agents Chemother; 2014 Sep; 58(9):5613-6. PubMed ID: 24982084 [Abstract] [Full Text] [Related]
12. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145 [Abstract] [Full Text] [Related]
13. Caspofungin acetate: an antifungal agent. Hoang A. Am J Health Syst Pharm; 2001 Jul 01; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878 [Abstract] [Full Text] [Related]